Literature DB >> 3278664

Mechanical ventilation after marrow transplantation. Risk factors and clinical outcome.

S W Crawford1, D A Schwartz, F B Petersen, J G Clark.   

Abstract

The risk factors for and the outcome of mechanical ventilatory support after marrow transplantation were analyzed in 1,089 consecutive marrow recipients. Of 232 patients receiving ventilatory support at this center, 63 (27%) survived an initial episode of ventilatory support. In contrast, 74% of nonventilated patients survived at least 6 months after transplantation. Among patients with malignant disease (n = 992), a multivariate regression model revealed 3 pretransplant factors that were associated with ventilatory support: age greater than or equal to 21 yr (RR = 1.6, 95% confidence intervals [Cl] = 1.3, 2.0), hematologic malignancy in relapse (RR = 2.1, 95% Cl = 1.7, 2.4), and HLA nonidentical donor-recipient pair (nonidentical graft) (RR = 1.7, 95% Cl = 1.4, 2.1). Survival after ventilatory support was not found to be associated with any pretransplant or post-transplant factors examined. We conclude that although the risk factors for mechanical ventilatory support after marrow transplantation can be defined, we are unable to identify characteristics predictive of survival after such support. The implications of these findings in relation to patient selection and future research activities are discussed.

Entities:  

Mesh:

Year:  1988        PMID: 3278664     DOI: 10.1164/ajrccm/137.3.682

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  17 in total

1.  The pulmonary complications of bone marrow transplantation in adults.

Authors:  P W Noble
Journal:  West J Med       Date:  1989-04

2.  Mechanical ventilation in bone marrow transplanted children; do they benefit?

Authors:  H T Henneveld; N M Wulffraat; R J Gemke; A J van Vught
Journal:  Eur J Pediatr       Date:  1998-05       Impact factor: 3.183

Review 3.  Aids and the lung. 6-- Management of respiratory failure in patients with the acquired immune deficiency syndrome and Pneumocystis carinii pneumonia.

Authors:  R F Miller; D M Mitchell
Journal:  Thorax       Date:  1990-02       Impact factor: 9.139

4.  Intensive care for patients with the acquired immunodeficiency syndrome.

Authors:  J M Luce; R M Wachter
Journal:  Intensive Care Med       Date:  1989       Impact factor: 17.440

5.  Is intensive care justified for patients with haematological malignancies?

Authors:  F Brunet; J J Lanore; J F Dhainaut; F Dreyfus; J F Vaxelaire; S Nouira; T Giraud; A Armaganidis; J F Monsallier
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

6.  Risk factors for acute respiratory distress syndrome during neutropenia recovery in patients with hematologic malignancies.

Authors:  Chin Kook Rhee; Ji Young Kang; Yong Hyun Kim; Jin Woo Kim; Hyung Kyu Yoon; Seok Chan Kim; Soon Suk Kwon; Young Kyoon Kim; Kwan Hyung Kim; Hwa Sik Moon; Sung Hak Park; Hee Je Kim; Seok Lee; Jeong Sup Song
Journal:  Crit Care       Date:  2009-11-03       Impact factor: 9.097

7.  Treatment of acute respiratory failure by helmet-delivered non-invasive pressure support ventilation in children with acute leukemia: a pilot study.

Authors:  Marco Piastra; Massimo Antonelli; Antonio Chiaretti; Giancarlo Polidori; Lorenzo Polidori; Giorgio Conti
Journal:  Intensive Care Med       Date:  2004-01-13       Impact factor: 17.440

8.  Predictive factors of intensive care unit admission in patients with haematological malignancies and pneumonia.

Authors:  Didier Gruson; Frederic Vargas; Gilles Hilbert; Nam Bui; Thierry Maillot; Thierry Mayet; Odile Pillet; Genevieve Chene; Georges Gbikpi-Benissan
Journal:  Intensive Care Med       Date:  2004-03-30       Impact factor: 17.440

9.  Early tracheotomy in neutropenic, mechanically ventilated patients: rationale and results of a pilot study.

Authors:  F Blot; M Guiguet; S Antoun; B Leclercq; G Nitenberg; B Escudier
Journal:  Support Care Cancer       Date:  1995-09       Impact factor: 3.603

10.  Improved survival of critically ill cancer patients with septic shock.

Authors:  Jérôme Larché; Elie Azoulay; Fabienne Fieux; Laurent Mesnard; Delphine Moreau; Guillaume Thiery; Michaël Darmon; Jean-Roger Le Gall; Benoît Schlemmer
Journal:  Intensive Care Med       Date:  2003-09-12       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.